UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 33 filers reported holding UNIQURE NV in Q2 2017. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $617 | -47.0% | 53,877 | -6.9% | 0.01% | -55.6% |
| Q1 2023 | $1,165 | +34.1% | 57,867 | +50.9% | 0.03% | +8.0% |
| Q4 2022 | $869 | -99.6% | 38,350 | +755.1% | 0.02% | +316.7% |
| Q2 2020 | $202,000 | -1.9% | 4,485 | +3.5% | 0.01% | -25.0% |
| Q1 2020 | $206,000 | -60.2% | 4,332 | -92.0% | 0.01% | -57.9% |
| Q3 2017 | $518,000 | +55.1% | 54,000 | 0.0% | 0.02% | +35.7% |
| Q2 2017 | $334,000 | +5.0% | 54,000 | -1.8% | 0.01% | +7.7% |
| Q1 2017 | $318,000 | +278.6% | 55,000 | +266.7% | 0.01% | +225.0% |
| Q4 2016 | $84,000 | -29.4% | 15,000 | +50.0% | 0.00% | -20.0% |
| Q1 2016 | $119,000 | -64.0% | 10,000 | -50.0% | 0.01% | -78.3% |
| Q4 2015 | $331,000 | +35.1% | 20,000 | +66.7% | 0.02% | +109.1% |
| Q3 2015 | $245,000 | +21.9% | 12,000 | -6.8% | 0.01% | +175.0% |
| Q1 2014 | $201,000 | – | 12,882 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |